Basics Marker Therapeutics, Inc. IPO Date: August 1, 2002 Sector: Healthcare Industry: Biotech Market Cap: $12.32M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.32% Avg Daily Range (30 D): $0.06 | 4.90% Avg Daily Range (90 D): $0.08 | 5.20% Institutional Daily Volume Avg Daily Volume: .47M Avg Daily Volume (30 D): .09M Avg Daily Volume (90 D): .1M Trade Size Avg Trade Size (Sh.): 318 Avg Trade Size (Sh.) (30 D): 299 Avg Trade Size (Sh.) (90 D): 240 Institutional Trades Total Inst.Trades: 23 Avg Inst. Trade: $2.23M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.02M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 106.23K         News Nov 26, 2024 @ 4:00 PM Marker Therapeutics to Present at the Citizens JMP... Source: N/A May 15, 2024 @ 8:15 PM Marker Therapeutics Reports First Quarter 2024 Fin... Source: Marker Therapeutics Apr 8, 2024 @ 11:00 AM Principal Investigator from City of Hope National ... Source: Marker Therapeutics Mar 25, 2024 @ 9:45 PM Marker Therapeutics Reports Year-End 2023 Corporat... Source: Marker Therapeutics Mar 22, 2024 @ 4:30 PM Marker Therapeutics to Present at the H.C. Wainwri... Source: Marker Therapeutics Financials   TTM Q1 2025 Q4 2024 Basic EPS $-1.33 $-.4 $-.42 Diluted EPS $-1.33 $-.4 $-.42 Revenue $ 5.7M $ .35M $ 2.25M Gross Profit $ $ $ Net Income / Loss $ -12.78M $ -4.45M $ -3.84M Operating Income / Loss $ -13.18M $ -4.61M $ -3.86M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Jan 27, 2023:   1:10 Sep 16, 2016:   1:12 Feb 25, 2014:   1:100 Jul 27, 2009:   1:10 Jun 28, 2007:   2:5 Jun 08, 2001:   1:50